Johannes Kehle

Johannes Kehle, PhD has a diverse and impressive work experience. Johannes served as the Vice President Global Molecular R&D at Quidel, where they successfully drove the development and launch of the molecular point-of-care platform "Savanna". Johannes also held the position of Managing Director at Quidel Germany GmbH, where they oversaw R&D, manufacturing, quality control, logistics, and distribution efforts. Johannes Kehle has also founded and worked as the CEO of AnDiaTec GmbH & Co. KG, a leading biotech company specializing in medical diagnostic devices. Johannes has also held significant roles at Enfer Diagnostics Ltd and Laboratory Prof. Enders. Additionally, they have extensive scientific research experience, having worked as a Scientific Researcher at the Max Planck Institute for Molecular Genetics.

Johannes Kehle, PhD earned their Bachelor of Science degree in Biology from the University of Tübingen in 1997. Johannes went on to complete their Master of Science degree at the same university in 1999, majoring in Genetics and minoring in Cell Biology and Paleontology. Johannes then pursued their Doctor of Philosophy (PhD) degree in Human Biology/Molecular Virology at Ulm University, completing it with Magna Cum Laude honors in 2004.